Overview

Paclitaxel and Cisplatin for Thymic Neoplasm

Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of the regimen in previously untreated, unresectable invasive thymoma or thymic carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Korean Cancer Study Group
Treatments:
Albumin-Bound Paclitaxel
Cisplatin
Paclitaxel